The World Health Organization approved two new candidate Ebola vaccines to join an ongoing clinical trial in the Democratic Republic of Congo.

What it means

The World Health Organization has approved two new experimental Ebola vaccine candidates — including one developed by the University of Oxford (ChAdOx1) — to be added to an ongoing clinical trial in the Democratic Republic of Congo. The trial targets the Bundibugyo strain of Ebola, which is driving the current outbreak, and marks the first time vaccines designed specifically for that strain are being tested in humans.

Accuracy & sourcesGrounded

The claim is directly sourced from a WHO announcement (November 4, 2026) and has been reported by multiple reputable outlets (UN News, Al Jazeera, AFP, etc.). The WHO is the named primary source, and the reporting closely reflects its press release, making the claim highly solid.

How new

Genuinely new — the WHO announcement and subsequent news articles were published on November 4–5, 2026.

Go deeper

• Anadolu Agency — first to publish